Literature DB >> 4203007

Impaired lymphocyte function in untreated Hodgkin's disease.

R Levy, H S Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4203007     DOI： 10.1056/NEJM197401242900402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

1.  B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors:  K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.

Authors:  S V Payne; D B Jones; D G Haegert; J L Smith; D H Wright
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

3.  Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

Authors:  C H Ten Napel; T H The; J Van Egten-Bijker; G C de Gast; M R Halie; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

4.  [Immunologic status in Hodgkin patients: correlation with Epstein-Barr virus titers].

Authors:  V Diehl; K Hegge; J Kalden; U Desselberger; P Krull
Journal:  Blut       Date:  1976-04

5.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors:  C Moroz; N Lahat; M Biniaminov; B Ramot
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

7.  Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

Authors:  Z Fuks; S Strober; A M Bobrove; T Sasazuki; A McMichael; H S Kaplan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Authors:  M M Bieber; Z Fuks; H S Kaplan
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

9.  [Lymphocyte stimulation of healthy probands with a "Hodgkin's HL-A type" (author's transl)].

Authors:  W Tittor; L Kredel; E Röck
Journal:  Klin Wochenschr       Date:  1976-10-15

10.  Reduced monocyte phagocytosis in patients with advanced Hodgkin's disease and lymphosarcoma.

Authors:  D Urbanitz; I Fechner; R Gross
Journal:  Klin Wochenschr       Date:  1975-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.